Synmosa Biopharma (ROCO:4114) Total Operating Expense : NT$1,516 Mil (TTM As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Synmosa Biopharma Total Operating Expense?

Synmosa Biopharma's Total Operating Expense for the three months ended in Mar. 2024 was NT$393 Mil. Synmosa Biopharma's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was NT$1,516 Mil.

Synmosa Biopharma Total Operating Expense Historical Data

The historical data trend for Synmosa Biopharma's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synmosa Biopharma Total Operating Expense Chart

Synmosa Biopharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

Get a 7-Day Free Trial

1,012.03

1,013.56

1,100.17

1,371.62

1,499.59

Synmosa Biopharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Operating Expense	Get a 7-Day Free Trial															376.29	370.72	369.91	382.67	393.01

Synmosa Biopharma Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$1,516 Mil.

Synmosa Biopharma Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Synmosa Biopharma's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Synmosa Biopharma (ROCO:4114) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Synmosa Biopharma Corp (ROCO:4114) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section 1, Neihu Road, 11th Floor, No. 396, Taipei, TWN, 114

Website

https://www.synmosa.com.tw

Synmosa Biopharma Corp is engaged in the research and development, manufacturing, marketing, and distribution of pharmaceutical products. It provides prescription, OTC medicines, and healthcare products under its Synmosa trademark. Its products concentrate on three therapeutic areas: Cardiovascular, Respiratory, and sex hormone. Its product lines are divided into cold series, nutritional supplement series, gastrointestinal series, skincare series, and hormone series.

Synmosa Biopharma (ROCO:4114) Headlines

No Headlines